Press Releases Edwards Lifesciences Corporation Swiss Exchange

Equities

EW

US28176E1082

Market Closed - Swiss Exchange Other stock markets 11:35:35 2019-06-27 am EDT			5-day change	1st Jan Change
60.6 ^CHF	-1.45%		-.--%	-.--%

Jul. 10	Citigroup Adjusts Price Target on Edwards Lifesciences to $106 From $105	MT
Jul. 02	Evercore ISI Adjusts Price Target on Edwards Lifesciences to $91 From $89, Maintains In-line Rating	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Kinstellar Has Successfully Advised Edwards Lifesciences In The Area Of Data Protection	Jul. 11	AQ
Five-Year Data Show Excellent Outcomes for Female and Small Annulus Patients With Edwards TAVR	Jun. 05	BU
BD to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion to Expand Smart Connected Care Solutions and Become an Advanced Monitoring Technology Leader	Jun. 03	PR
Edwards Lifesciences to Sell Critical Care to BD	Jun. 03	BU
Edwards Lifesciences : Charter of the Audit Committee	May. 27	PU
Edwards Lifesciences : First Quarter 2024 Fact Sheet	May. 15	PU
Edwards Launches the SAPIEN 3 Ultra RESILIA Valve in Europe With Technology to Enhance Durability	May. 08	BU
Edwards Lifesciences: Q1 Earnings Snapshot	Apr. 25	AQ
Edwards Lifesciences Reports First Quarter Results	Apr. 25	BU
Edwards Lifesciences to Host Earnings Conference Call on April 25, 2024	Apr. 18	BU
Edwards Lifesciences - Study of NFL Alumni Cohort Finds Majority Suffer From Heart Disease without Knowing It	Apr. 08	AQ
Study of NFL Alumni Cohort Finds Majority Suffer From Heart Disease Without Knowing It	Apr. 07	BU
Precedential Federal Circuit Opinion Underscores Tension In Interpretation Of The Safe Harbor Of 35 U.S.C. § 271(e)(1)	Apr. 03	AQ
Large, Real-world Studies Demonstrate Continued Excellent Outcomes for Patients Receiving Edwards SAPIEN TAVR	Mar. 11	BU
EDWARDS LIFESCIENCES TO PRESENT AT THE 44TH ANNUAL TD COWEN HEALTHCARE CONFERENCE	Feb. 26	AQ
Edwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare Conference	Feb. 23	BU
Edwards Lifesciences: Q4 Earnings Snapshot	Feb. 06	AQ
Edwards Lifesciences Reports Fourth Quarter Results	Feb. 06	BU
Edwards’ EVOQUE Valve Replacement System First Transcatheter Therapy to Earn FDA Approval for Tricuspid Valve	Feb. 02	BU
Edwards Lifesciences to Host Earnings Conference Call on February 6, 2024	Jan. 30	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Edwards Lifesciences Corporation: The story continues

April 23, 2024 at 11:25 am EDT